Molecular characterisation and evaluation of neutral sphingomyelinase 2 as a novel target in multiple myeloma
Funding or Partner Organisation: Cancer Australia (Priority-driven Collaborative Cancer Research Scheme)
Start year: 2013
FOR Codes: Molecular Targets, Cancer and Related Disorders, Clinical health